Clinical Laboratory Services Market Gains Momentum with Diagnostic Advances

The global clinical laboratory services market was estimated at USD 233.63 billion in 2024 and is projected to reach USD 286.77 billion by 2030, representing a compound annual growth rate (CAGR) of 3.82 % between 2025 and 2030. Growth is being driven by an increasing burden of chronic diseases and rising demand for early diagnostic testing capabilities.

Key Market Trends & Insights

North America held the largest share of the market in 2024, accounting for 37.24 % of revenues. The Asia Pacific region is expected to post the highest growth rate, with a projected CAGR of 5.30 % over the forecast period. When looking by test type, the clinical chemistry segment dominated with a 56.60 % share in 2024. In terms of service provider, hospital-based laboratories led the market in 2024, while by application the bioanalytical & lab chemistry services segment claimed the largest revenue share in that year.

Market Size & Forecast

In 2024 the market size stood at USD 233.63 billion; by 2030 it is projected to reach USD 286.77 billion, reflecting a CAGR of 3.82 % over 2025-2030. North America remains the largest regional market in 2024, while Asia Pacific is on track to grow the fastest across the forecast period. The market’s upward trajectory is reinforced by diagnostic labs’ shifting role: beyond routine chemistry and hematology tests they are increasingly embracing molecular diagnostics, genetic testing, precision medicine and next-generation sequencing (NGS). The service provider landscape is also evolving: hospital-based labs dominate today, yet standalone or clinic-based labs are gaining momentum thanks to lower costs, faster turnaround times and increased patient outreach programs. In application terms, bioanalytical & lab chemistry services currently lead, while toxicology testing, cell & gene therapy related services, and drug discovery-related laboratory services are expected to show higher growth.

Order a free sample PDF of the Clinical Laboratory Services Market Intelligence Study, published by Grand View Research.

Key Companies & Market Share Insight

The industry is marked by moderate innovation and high competitive intensity, underpinned by continuous technological evolution—from automation of sample preparation to digital health integration and high-throughput analytics. Several major strategic acquisitions illustrate this dynamic: in January 2023, for example, the launch of an in-vitro diagnostics platform that purifies RNA/DNA in 30 minutes underscored the shift toward rapid turnaround genomics-friendly services. In February 2022, a leading laboratory services company acquired a genomics-based oncology diagnostics firm to bolster its next-generation sequencing capabilities.

Regulatory frameworks are well-established, particularly in the U.S., where the Clinical Laboratory Improvement Amendments (CLIA) and the Food and Drug Administration (FDA) play key roles in assuring test quality and safety. Market growth is accelerated by adoption of digital pathology, artificial intelligence, machine-learning workflows and at-home testing kits, all of which expand access and efficiency of laboratory services globally. Geographically, players are extending their reach beyond established markets into Asia Pacific, Latin America, Middle East and Africa, capitalising on rising healthcare investment, unmet diagnostic needs, and digital infrastructure deployment.

Key Companies List

Major companies that dominate the clinical laboratory services market include:

• Laboratory Corporation of America Holdings (LabCorp)
• QIAGEN NV
• Eurofins Scientific SE
• Quest Diagnostics Incorporated
• OPKO Health, Inc.
• Siemens Healthineers AG
• NeoGenomics Laboratories
• Fresenius Medical Care
• ARUP Laboratories
• Sonic Healthcare Limited
• Charles River Laboratories
• SYNLAB International
• Mayo Clinic Laboratories
• Unilabs

These organisations collectively control a significant portion of the market, set competitive benchmarks, lead technological development and expand via partnerships, mergers and geographic outreach.

Conclusion

Overall, the clinical laboratory services market is firmly on a growth path, supported by rising chronic-disease prevalence, technological innovation, automation and increasing demand for precision diagnostics. As hospital-based laboratories maintain dominance, standalone labs and service applications such as toxicology, cell & gene therapy and bioanalytical chemistry are gaining prominence. Companies that continue to invest in genomic platforms, digital workflows and international expansion are poised to capture substantial value in the evolving diagnostic services landscape.

Explore Horizon Databook – The world’s most expansive market intelligence platform developed by Grand View Research.